Predicting success of nerve block for migraine
Part of Brain & nervous system clinical trials.
This study looks at whether a nerve block injection at the back of the head (greater occipital nerve block) helps people with migraine. It aims to find out who is most likely to benefit from this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with migraine for at least 6 months
- You are between 18 and 65 years old
- You have tried at least one preventive migraine medicine for 3 months without good results
- You are about to get your first greater occipital nerve block injection
- You are not pregnant or breastfeeding
- You do not have cancer, a bleeding disorder, or take blood thinners
- You have no infection or open wound at the back of your head
- You have not had a migraine intervention (like Botox or acupuncture) in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests which nerve block works better for stubborn migraines: one on the stellate ganglion (a cluster of nerves in the neck) or the greater occipital nerve (at the back of the head). They will also check how these blocks affect a chemical linked to migraine pain. If you have chronic migraines that haven't improved with multiple treatments, you may be eligible.
This trial tests if injections around nerves in the head and neck can improve sleep for people with long-lasting headaches that haven't gotten better with standard treatments. It may help you if you have daily or near-daily headaches and are looking for a non-medication option.
This study compares two nerve block treatments for chronic migraine pain. One group gets a single nerve block in the back of the head, while the other gets nerve blocks in the back of the head and behind the ear. This will help see if adding the second injection offers more pain relief.
This trial tests two treatments—botulinum toxin injections and nerve blocks in the neck—to reduce migraine frequency in people who have migraines on 15 or more days per month. Either or both treatments may help prevent migraines.
This trial tests whether a nerve-blocking injection in the back of the head can help people with migraine who are taking too much headache medication. The injection uses a steroid and local anesthetic to reduce nerve signals that cause migraine pain.
This trial tests if using ultrasound-guided heat (radiofrequency ablation) on the occipital nerve can reduce headache pain. It is for people with occipital neuralgia or migraine pain at the back of the head who haven't had enough relief from oral medications.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.